Literature DB >> 31171120

Hereditary Cancer Syndromes-A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer Syndromes.

N Jewel Samadder1, Noemi Baffy2, Karthik V Giridhar3, Fergus J Couch4, Douglas Riegert-Johnson5.   

Abstract

Hereditary causes due to mutations and defects in certain genes account for roughly 5% to 10% of all colorectal cancers. These inherited syndromes have been associated with a 60% to 100% lifetime risk for development of colorectal cancer, depending on the genetic syndrome, and many also carry an increased risk for multiple extracolonic malignancies. In this second part of a review series on hereditary cancer syndromes, the focus will be to provide guidance on the features and management of the most commonly encountered hereditary colorectal cancers and polyposis conditions including Lynch syndrome, familial adenomatous polyposis, MUTYH-associated polyposis, and hamartomatous polyposis.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31171120     DOI: 10.1016/j.mayocp.2019.01.042

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

Review 1.  Hereditary Polyposis Syndromes.

Authors:  Trilokesh D Kidambi; Divyanshoo R Kohli; N Jewel Samadder; Aparajita Singh
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 2.  How many is too many? Polyposis syndromes and what to do next.

Authors:  Nina Gupta; Christine Drogan; Sonia S Kupfer
Journal:  Curr Opin Gastroenterol       Date:  2022-01-01       Impact factor: 3.287

3.  Using genotype to assist clinical surveillance: a retrospective study of Chinese familial adenomatous polyposis patients.

Authors:  Sai Ge; Duo Cheng; Xuhui Zhang; Ting Xu; Zhenghang Wang; Fengxiao Dong; Lan Su; Jinlei Song; Jia Wang; Jian Li; Lin Shen; Xicheng Wang
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

4.  Genetic Gastric Cancer Risk Syndromes.

Authors:  Benjamin A Lerner; Xavier Llor
Journal:  Curr Treat Options Gastroenterol       Date:  2020-10-19

Review 5.  Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations.

Authors:  Alessandro Vanoli; Federica Grillo; Daniela Furlan; Giovanni Arpa; Oneda Grami; Camilla Guerini; Roberta Riboni; Luca Mastracci; Antonio Di Sabatino
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.

Authors:  Zoran Gatalica; Semir Vranic; Božo Krušlin; Kelsey Poorman; Phillip Stafford; Denisa Kacerovska; Wijendra Senarathne; Elena Florento; Elma Contreras; Alexandra Leary; April Choi; Gino K In
Journal:  Cancer Med       Date:  2020-01-03       Impact factor: 4.452

7.  Genetic Testing and/or Counseling for Colorectal Cancer by Health Insurance Type.

Authors:  Arian Mansur; Fang Zhang; Christine Y Lu
Journal:  J Pers Med       Date:  2022-07-15

8.  A Previously Unrecognized Molecular Landscape of Lynch Syndrome in the Mexican Population.

Authors:  Alejandra Padua-Bracho; José A Velázquez-Aragón; Verónica Fragoso-Ontiveros; Paulina María Nuñez-Martínez; María de la Luz Mejía Aguayo; Yuliana Sánchez-Contreras; Miguel Angel Ramirez-Otero; Marcela Angélica De la Fuente-Hernández; Silvia Vidal-Millán; Talia Wegman-Ostrosky; Abraham Pedroza-Torres; Cristian Arriaga-Canon; Luis A Herrera-Montalvo; Rosa Maria Alvarez-Gómez
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

Review 9.  Time to Classify Tumours of the Stomach and the Kidneys According to Cell of Origin.

Authors:  Helge Waldum; Patricia Mjønes
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

10.  mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-BMPR1A deletion.

Authors:  Henry Taylor; Dilay Yerlioglu; Claudia Phen; Antje Ballauff; Natalia Nedelkopoulou; Isabel Spier; Inés Loverdos; Veronica B Busoni; Jürgen Heise; Peter Dale; Tim de Meij; Kevin Sweet; Marta C Cohen; Victor L Fox; Emmanuel Mas; Stefan Aretz; Charis Eng; Stephan Buderus; Mike Thomson; Isabel Rojas; Holm H Uhlig
Journal:  Hum Mol Genet       Date:  2021-06-26       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.